Fracture healing in a polytrauma rat model is influenced by mtDNA:cGAS complex mediated pro-inflammation

Preeti J Muire1,2, Alicia L Lofgren3, Stefanie M Shiels3

  • 1Combat Wound Care, US Army Institute of Surgical Research, JBSA Ft Sam Houston, San Antonio, TX, 78234, USA. preetimuire@gmail.com.

PubMed
Abstract

Insights

The cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) pathway impacts delayed bone healing after severe trauma. Inhibiting this pathway with RU.521 improved fracture repair in a polytrauma rat model.

Area of Science:

  • Immunology
  • Biomedical Engineering
  • Molecular Biology

Background:

  • The cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) pathway is crucial for immune responses in autoimmune diseases and cancer.
  • Its role in fracture healing following severe trauma remains largely unexplored.

Purpose of the Study:

  • To investigate the involvement of the cGAS-STING signaling pathway in delayed bone healing associated with polytrauma (PT) fractures.
  • To determine if inhibiting the cGAS-STING pathway can enhance fracture healing in a PT model.

Main Methods:

  • Preliminary dosage determination of the cGAS inhibitor RU.521 in mice.
  • Quantification of plasma mitochondrial DNA (mtDNA) in a clinically relevant PT rat model (burn, blunt trauma, femoral fracture).
  • Assessment of bone regeneration via radiography and histology in PT rats treated with RU.521 or vehicle.

Main Results:

  • Elevated plasma mtDNA levels were observed in PT rats at 3 hours post-trauma.
  • Treatment with RU.521 significantly improved bone healing in PT rats compared to vehicle controls.
  • IFNβ levels were decreased in the BALF of RU.521 treated mice at 24 hours.

Conclusions:

  • The cGAS-STING signaling pathway plays a significant role in trauma-induced delayed bone healing.
  • Further research is needed to elucidate the cellular and molecular mechanisms for augmenting PT-associated healing deficits.